These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 218089

  • 1. Identity of [3H]-dihydroalprenolol binding sites and beta-adrenergic receptors coupled with adenylate cyclase in the central nervous system: pharmacological properties, distribution and adaptive responsiveness.
    Dolphin A, Adrien J, Hamon M, Bockaert J.
    Mol Pharmacol; 1979 Jan; 15(1):1-15. PubMed ID: 218089
    [No Abstract] [Full Text] [Related]

  • 2. Ectopic beta-adrenergic receptor binding sites. possible molecular basis of aberrant catecholamine responsiveness of an adrenocortical tumor adenylate cyclase.
    Williams LT, Gore TB, Lefkowitz RJ.
    J Clin Invest; 1977 Feb; 59(2):319-24. PubMed ID: 13086
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Agonist- induced transconformation of beta-adrenergic receptors, and adenylate cyclase activation [proceedings].
    Vauquelin G, Bottari S, Strosberg AD.
    Arch Int Physiol Biochim; 1979 Oct; 87(4):859-60. PubMed ID: 93949
    [No Abstract] [Full Text] [Related]

  • 6. Molecular pharmacology of adenylate cyclase-coupled alpha- and beta-adrenergic receptors.
    Lefkowitz RJ, De Lean A, Hoffman BB, Stadel JM, Kent R, Michel T, Limbird L.
    Adv Cyclic Nucleotide Res; 1981 Oct; 14():145-61. PubMed ID: 6269377
    [No Abstract] [Full Text] [Related]

  • 7. Chemical modification of the beta adrenergic receptors coupled with adenylate cyclase by disulfide bridge-reducing agents.
    Lucas M, Hanoune J, Bockaert J.
    Mol Pharmacol; 1978 Mar; 14(2):227-36. PubMed ID: 205769
    [No Abstract] [Full Text] [Related]

  • 8. Altered responsiveness of cerebral beta adrenoceptors assessed by adenosine cyclic 3',5'-monophosphate formation and (3H)propranolol binding.
    Nahorski SR.
    Mol Pharmacol; 1977 Jul; 13(4):679-89. PubMed ID: 196175
    [No Abstract] [Full Text] [Related]

  • 9. Molecular mechanisms of activation and desensitization of adenylate cyclase coupled beta-adrenergic receptors.
    Lefkowitz RJ, Williams LT.
    Adv Cyclic Nucleotide Res; 1978 Jul; 9():1-17. PubMed ID: 208372
    [No Abstract] [Full Text] [Related]

  • 10. Electroconvulsive treatment: rapid subsensitivity of the norepinephrine receptor coupled adenylate cyclase system in brain linked to down regulation of beta-adrenergic receptors.
    Gillespie DD, Manier DH, Sulser F.
    Commun Psychopharmacol; 1979 Jul; 3(3):191-5. PubMed ID: 227643
    [No Abstract] [Full Text] [Related]

  • 11. Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist.
    Scarpace PJ, Abrass IB.
    J Pharmacol Exp Ther; 1982 Nov; 223(2):327-31. PubMed ID: 6127402
    [Abstract] [Full Text] [Related]

  • 12. Age-related alterations in the development of adrenergic denervation supersensitivity.
    Weiss B, Greenberg L, Cantor E.
    Fed Proc; 1979 Apr; 38(5):1915-21. PubMed ID: 218849
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adenylate cyclase and beta adrenergic receptor development in the mouse heart.
    Chen FC, Yamamura HI, Roeske WR.
    J Pharmacol Exp Ther; 1982 Jul; 222(1):7-13. PubMed ID: 6283073
    [Abstract] [Full Text] [Related]

  • 15. Characteristics of (-)-[3H]-dihydroalprenolol binding to beta-adrenoceptors on rat lung membranes [proceedings].
    Barnett DB, Nahorski SR, Rugg EL.
    Br J Pharmacol; 1977 Nov; 61(3):459P. PubMed ID: 201324
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of adenylate cyclase-coupled beta adrenergic receptor binding sites by beta adrenergic catecholamines in vitro.
    Mickey JV, Tate R, Mullikin D, Lefkowitz RJ.
    Mol Pharmacol; 1976 May; 12(3):409-19. PubMed ID: 934056
    [No Abstract] [Full Text] [Related]

  • 17. Effects of 6-hydroxydopamine on the development of the beta adrenergic receptor/adenylate cyclase system in rat cerebral cortex.
    Harden TK, Wolfe BB, Sporn JR, Poulos BK, Molinoff PB.
    J Pharmacol Exp Ther; 1977 Oct; 203(1):132-43. PubMed ID: 198523
    [No Abstract] [Full Text] [Related]

  • 18. [3H]dihydroalprenolol binding in the rat brainstem.
    Stone EA, U'Prichard DC.
    Eur J Pharmacol; 1981 Oct 22; 75(2-3):159-61. PubMed ID: 6119217
    [Abstract] [Full Text] [Related]

  • 19. Characterization and differential in vivo regulation of brain adrenergic receptor subtypes.
    U'Prichard DC, Yamamura HI, Reisine TD.
    Adv Biochem Psychopharmacol; 1980 Oct 22; 21():213-21. PubMed ID: 6103648
    [No Abstract] [Full Text] [Related]

  • 20. beta-Adrenergic receptor: ligand binding properties and the interaction with adenylyl cyclase.
    Maguire ME, Ross EM, Gilman AG.
    Adv Cyclic Nucleotide Res; 1977 Oct 22; 8():1-83. PubMed ID: 21549
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.